Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, T6G 2P5, Canada.
Sci Rep. 2017 Aug 10;7(1):7819. doi: 10.1038/s41598-017-07908-z.
Amphipathic peptides are versatile building blocks for fabricating well-ordered nanostructures, which have gained much attention owing to their enormous design possibilities and bio-functionalities. However, using amphipathic peptides from natural proteins to create tunable nanostructures is challenging because of their heterogeneity and great tendency to form aggregates. Here we fabricated two well-defined nanoparticles from cruciferin amphipathic peptides by integrating top-down and bottom-up approach. Alkali hydrolysis (pH 12, 120 °C for 30 min) was introduced to break down intact cruciferin into peptides (top-down). The cruciferin peptides and their fractions were then assembled into nanoparticles (bottom-up) in the presence of calcium ions. The permeate fraction from 10 kDa cut-off membrane formed smaller nanoparticles (F1-NPs) (around 82 nm) than that of unfractionated cruciferin peptides (CRU-NPs, around 185 nm); the electrostatic and hydrophobic interactions were the main driving forces for particle formation. LC-MS/MS analysis characterised that the small amphipathic peptides (XZXZ, n = 0~5), composed of alternating hydrophobic (X) and hydrophilic (Z) amino acid with a length of 5-15 and 5-20 residues for F1-NPs and CRU-NPs, respectively, were responsible for particle formation. Our study established the mechanism of particle formation of the cold gelation is through assembly of amphipathic peptides.
两亲肽是构建有序纳米结构的多功能构建模块,由于其巨大的设计可能性和生物功能性,引起了广泛关注。然而,由于其异质性和易于聚集的倾向,使用天然蛋白质中的两亲肽来创建可调谐的纳米结构具有挑战性。在这里,我们通过整合自上而下和自下而上的方法,从芸薹素两亲肽中制备了两种明确的纳米粒子。碱水解(pH 12,120°C 30 分钟)用于将完整的芸薹素分解成肽(自上而下)。然后,在钙离子存在下,芸薹素肽及其级分被组装成纳米颗粒(自下而上)。10 kDa 截留膜的透过部分形成更小的纳米颗粒(F1-NPs)(约 82nm),而未分级的芸薹素肽(CRU-NPs)(约 185nm)则形成更大的纳米颗粒;静电和疏水相互作用是颗粒形成的主要驱动力。LC-MS/MS 分析表明,由交替的疏水性(X)和亲水性(Z)氨基酸组成的小两亲肽(XZXZ,n=0~5),长度分别为 5-15 和 5-20 个残基,负责形成 F1-NPs 和 CRU-NPs。我们的研究建立了冷凝胶化颗粒形成的机制,即通过两亲肽的组装。